← FDA DRUG APPROVALS

FDA ANDA · ANDA211767

CLOMIPRAMINE HYDROCHLORIDE

Sponsor: MANKIND PHARMA

APPLICATION
ANDA211767
TYPE
ANDA
ORIGINAL APPROVAL
2019-04-08
LATEST ACTION
2023-10-13
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

CLOMIPRAMINE HYDROCHLORIDEPrescription
CLOMIPRAMINE HYDROCHLORIDE 50MG · CAPSULE · ORAL
CLOMIPRAMINE HYDROCHLORIDEPrescription
CLOMIPRAMINE HYDROCHLORIDE 75MG · CAPSULE · ORAL
CLOMIPRAMINE HYDROCHLORIDEPrescription
CLOMIPRAMINE HYDROCHLORIDE 25MG · CAPSULE · ORAL

Approval history

2023-10-13Manufacturing (CMC) · Supplement 15 · unknownAP
2023-09-21Labeling · Supplement 11 · standardAP
2023-09-21Labeling · Supplement 18 · standardAP
2023-09-21Labeling · Supplement 3 · standardAP
2019-04-08UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →